Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,766,329
+$727,522 QoQ
Shares Held
20,734
+31.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#225
of 477 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. CYTK ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
57,520 | $18,181,496 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
22,850 | $5,592,994 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,719 | $4,813,105 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
42,012 | $2,308,139 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
57,854 | $2,256,884 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,677 | $1,974,365 | |
| 7 | ZYME |
Zymeworks Inc.
|
71,660 | $1,873,192 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
23,272 | $1,845,236 |
All Filings in CYTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,766,329 | 20,734 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,038,807 | 15,761 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $976,991 | 15,376 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $957,018 | 17,413 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $548,530 | 16,602 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $683,350 | 17,003 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $793,235 | 16,863 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $899,289 | 17,032 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $864,171 | 15,950 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $1,120,708 | 15,985 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,429,432 | 17,121 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $542,535 | 18,416 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $660,391 | 20,245 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $702,040 | 19,950 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $852,297 | 18,601 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $756,159 | 15,607 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $621,489 | 15,818 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $638,690 | 17,351 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $768,569 | 16,862 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $691,390 | 19,345 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $498,925 | 25,211 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $588,989 | 25,322 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||